Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T00:31:53.504Z Has data issue: false hasContentIssue false
  • English
  • Français

Hemorrhage After Coronary Artery Bypass Graft Procedures

Published online by Cambridge University Press:  02 January 2015

Loreen A Herwaldt ,
Sheri K. Swartzendruber ,
M. Bridget Zimmerman ,
David A. Scholz ,
Jo Ann Franklin  and
Christopher A. Caldarone
Loreen A Herwaldt*
Affiliation:
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa University of Iowa Health Care, Iowa City, Iowa University of Iowa College of Public Health, Iowa City, Iowa
Sheri K. Swartzendruber
Affiliation:
University of Iowa Health Care, Iowa City, Iowa
M. Bridget Zimmerman
Affiliation:
University of Iowa College of Public Health, Iowa City, Iowa
David A. Scholz
Affiliation:
University of Iowa College of Public Health, Iowa City, Iowa
Jo Ann Franklin
Affiliation:
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, Iowa
Christopher A. Caldarone
Affiliation:
Department of Surgery, University of Iowa College of Medicine, Iowa City, Iowa
*
Clinical Outcomes and Resource Management, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, IA 52242-1081
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To identify risk factors for excessive bleeding after coronary artery bypass graft (CABG) procedures and to quantify the outcomes related to this complication.

Design:

We conducted a case–control study to identify risk factors for hemorrhage following CABG surgery and a historical cohort study to quantify outcomes of hemorrhage.

Setting:

The cardiothoracic surgery service of a university hospital.

Results:

Factors associated with excessive blood loss were recent catheterization (odds ratio [OR] = 0.44; 95% confidence interval [CI95], 0.21 to 0.91); age older than 65 years (OR = 1.94; CI95, 0.96 to 3.93); bypass time of 150 minutes or more (OR = 2.91; CI95, 1.09 to 7.81); and postoperative platelet count of 160,000/mm3 or less (OR = 2.36; CI95, 1.06 to 5.22). The attributable cost of a postoperative hemorrhage was $3,866 (P = .0002) overall, $9,912 (P = .0001) for patients who required reoperation, and $3,316 (P = .03) for those treated medically. The median attributable postoperative length of stay was 1 day longer for cases than for controls (P = .011). Postoperatively, patients who hemorrhaged received significantly larger volumes of packed red blood cells (P < .0001), fresh frozen plasma (P < .0001), platelets (P < .0001), plasminate (P = .007), protamine sulfate (P < .0001), desmopressin acetate (P < .0001), and epsilon-aminocaproic acid (P < .0001) than did controls.

Conclusions:

Age, duration of bypass, and postoperative platelet count were associated with excessive bleeding. Hemorrhage after CABG surgery significantly increased the length of stay and cost of care.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 24 , Issue 1 , January 2003 , pp. 44 - 50
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Herwaldt, LA, Swartzendruber, SK, Edmond, MB, et al. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol 1998;19:9–16.Google Scholar
2.Turnan, KJ, McCarthy, RJ, O'Connor, CJ, McCarthy, WE, Ivankovich, AD. Aspirin does not increase allogeneic blood transfusion in reoperative coronary artery surgery. Anesth Analg 1996;83:1178–1184.Google Scholar
3.Dacey, LJ, Munoz, JJ, Baribeau, YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Arch Surg 1998;133:442–447.Google Scholar
4.Hammermeister, KE, Burchfiel, C, Johnson, R, Grover, FL. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 1990;82(suppl IV):IV–380-IV-389.Google ScholarPubMed
5.Brown, RS, Thwaites, BK, Mongan, PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesth Analg 1997;85:963–970.CrossRefGoogle ScholarPubMed
6.Misfeld, M, Dubbert, S, Eleftheriadis, S, et al. Fibrinolysis-adjusted peri-operative low-dose aprotinin reduces blood loss in bypass operations. Ann Thorac Surg 1998;66:792–799.Google Scholar
7.Royston, D. High-dose aprotinin therapy: a review of the first five years' experience. J Cardiothorac Anesth 1992;6:76–100.CrossRefGoogle ScholarPubMed
8.Hayashida, N, Isomura, T, Sato, T, et al. Effects of minimal-dose aprotinin on coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997;114:261–269.Google Scholar
9.De Bonis, M, Cavliere, F, Alessandrini, F, et al. Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg 2000;119:575–580.Google Scholar
10.Bidstrup, BP, Hunt, BJ, Sheikh, S, et al. Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting. Ann Thorac Surg 2000;69:541–547.Google Scholar
11.Sethi, GK, Copeland, JG, Moritz, T, et al. Comparison of postoperative complications between saphenous vein and IMA grafts to left anterior descending coronary artery. Ann Thorac Surg 1991;51:733–738.CrossRefGoogle ScholarPubMed
12.Ferraris, VA, Ferraris, SP, Lough, FC, Berry, WR. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg 1988;45:71–74.Google Scholar
13.Michelson, F, Morganroth, J, Torosian, M, MacVaugh, H III. Relation of preoperative use of aspirin to increased mediastinal blood loss after coronary artery bypass surgery. J Thorac Cardiovasc Surg 1978;76:694–697.Google Scholar
14.U.S. Department of Labor, Bureau of Labor Statistics. Consumer Price Index: All Urban Consumers, Medical Care Component. Washington, DC: Bureau of Labor Statistics; 1998. Series Catalog ID: CUUR0000SA5.Google Scholar
15.Taylor, GJ, Mikell, FL, Moses, HW, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol 1990;65:309–313.Google Scholar
16.Gomes, MMR, McGoon, DC. Bleeding patterns after open-heart surgery. J Thorac Cardiovasc Surg 1970;60:87–97.Google Scholar
17.Despotis, GJ, Filos, KS, Zoys, TN, et al. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996;82:13–21.Google Scholar
18.Kshettry, VR, Flavin, TF, Emery, RW, et al. Does multivessel, off-pump coronary artery bypass reduce postoperative morbidity? Ann Thorac Surg 2000;69:1725–1731.CrossRefGoogle ScholarPubMed
19.Fremes, SE, Wong, BI, Lee, E, et al. Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg 1994;58:1580–1588.Google Scholar
20.Cicek, S, Demirkilic, U, Kuralay, E, Ozal, E, Tatar, H. Postoperative aprotinin: effect on blood loss and transfusion requirements in cardiac operations. Ann Thorac Surg 1996;61:1372–1376.CrossRefGoogle ScholarPubMed
21.Kallis, P, Tooze, JA, Talbot, S, et al. Aprotinin inhibits fibrinolysis, improves platelet adhesion and reduces blood loss: results of a double-blind randomized clinical trial. Eur J Cardio-Thorac Surg 1994;8:315–322.CrossRefGoogle ScholarPubMed
22.Bennett-Guerrero, E, Sorohan, JG, Gurevich, ML, et al. Cost-benefit and efficacy of aprotinin compared with ε-aminocaproic acid in patients having repeated cardiac operations. Anesthesiology 1997;87:1373–1380.Google Scholar
23.Lazzara, RR, radwell, FE, Kraemer, MF, Wood, JA, Starr, A. Reduction in costs, blood products, and operating time in patients undergoing open heart surgery. Arch Surg 1997;132:858–861.CrossRefGoogle ScholarPubMed
24.Ray, MJ, Brown, KF, Burrows, CA, O'Brien, MF. Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass. Ann Thorac Surg 1999;68:940–945.Google Scholar
25.Harmon, DE. Cost/benefit analysis of pharmacologic hemostasis. Ann Thorac Surg 1996;61:S21–S25.Google Scholar